Lipocine Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
-
15.00
26.70
32.00
28.40
-
Gross Income
-
15.00
26.70
32.00
28.40
-
SG&A Expense
8,736.80
20,206.80
18,355.30
18,426.20
21,189.60
11,735.30
EBIT
8,758.60
20,221.80
18,382.10
18,458.20
21,218.00
11,325.80
Unusual Expense
1,925.10
259.00
-
728.60
-
-
Non Operating Income/Expense
-
-
173.90
216.10
235.80
-
Pretax Income
10,645.20
20,372.50
18,208.20
18,970.80
20,982.20
11,659.30
Income Tax
55.00
0.20
0.20
0.80
0.70
0.70
Consolidated Net Income
10,590.10
20,372.70
18,208.40
18,971.50
20,982.90
11,660
Net Income
10,590.10
20,372.70
18,208.40
18,971.50
20,982.90
11,660
Net Income After Extraordinaries
10,590.10
20,372.70
18,208.40
18,971.50
20,982.90
11,660
Net Income Available to Common
10,590.10
20,372.70
18,208.40
18,971.50
20,982.90
11,660
EPS (Basic)
1.44
1.60
1.11
1.04
1.05
0.55
Basic Shares Outstanding
7,363.10
12,766.30
16,470.80
18,258.10
20,051.90
21,352.30
EPS (Diluted)
1.44
1.60
1.11
1.04
1.05
0.55
Diluted Shares Outstanding
7,363.10
12,766.30
16,470.80
18,258.10
20,051.90
21,352.30
EBITDA
8,736.80
20,206.80
18,355.40
18,426.20
21,189.60
11,307.20
Non-Operating Interest Income
38.50
108.30
-
-
-
459.50
About Lipocine
View Profile
